Published in Hepatitis Weekly, June 19th, 2006
Study 1: A study from Brazil has chronicled the determination of the cut-off value of serum Ala aminotransferase (ALT) in patients undergoing chronic hemodialysis (HD) to identify biochemical activity in patients with hepatitis C virus (HCV) viremia.
"Elevated liver enzymes are infrequent in patients with HCV infection undergoing chronic HD, suggesting that the ALT is a poor predictor of hepatocellular damage in this population," wrote E.P.A. Lopes and colleagues, Federal University of Pernambuco. "To establish a more appropriate cut-off value of ALT to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.